Nanomedicine: pharmacological perspectives

被引：15
|
作者：
Bhattacharya, Santanu [1 ]
Alkharfy, Khalid M. [2 ,3 ]
Janardhanan, Rajiv [4 ]
Mukhopadhyay, Debabrata [1 ,5 ]
机构：
[1] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[2] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia
[3] King Saud Univ, Biomarkers Res Program, Riyadh, Saudi Arabia
[4] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Biomed Engn, Rochester, MN 55905 USA
来源：
NANOTECHNOLOGY REVIEWS | 2012年 / 1卷 / 03期
基金：
美国国家卫生研究院;
关键词：
nanomedicine; pharmacodynamics; pharmacogenetics; pharmacokinetics; toxicity; SOLID LIPID NANOPARTICLES; LIPOSOME-BASED CARRIER; SUPERPARAMAGNETIC IRON-OXIDE; PLURONIC BLOCK-COPOLYMERS; POLYION COMPLEX MICELLES; WALLED CARBON NANOTUBES; IN-VIVO BIODISTRIBUTION; DRUG-DELIVERY SYSTEMS; SILICA NANOPARTICLES; CANCER-THERAPY;
D O I：
10.1515/ntrev-2011-0010
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Rapid developments in the field of nanotechnology are generating enormous interest in prospecting the potential of multifunctional therapeutic nanovectors in the field of personalized medicine. Although the nanomaterials are of same dimensions to many cellular machineries, their interaction with cells, tissues and organs of the body are not well understood. This in turn forms the rationale for a comprehensive study of these nanoplatforms in various disease models in terms of their toxicity, pharmacokinetics, pharmacodynamics, and pharmacogenetics. Such a study will significantly aid in our quest in translating its application from bench to bedside.
引用
下载
收藏
页码：235 / 253
页数：19
相关论文
共 50 条
  • [1] New perspectives in nanomedicine
    Thorley, Andrew J.
    Tetley, Teresa D.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 140 (02) : 176 - 185
  • [2] Glycans in nanomedicine, impact and perspectives
    Sampaolesi, Susanna
    Nicotra, Francesco
    Russo, Laura
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (01) : 43 - +
  • [3] Nanomedicine-Challenge and Perspectives
    Riehemann, Kristina
    Schneider, Stefan W.
    Luger, Thomas A.
    Godin, Biana
    Ferrari, Mauro
    Fuchs, Harald
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (05) : 872 - 897
  • [4] Perspectives and opportunities for nanomedicine in the management of atherosclerosis
    Mark E. Lobatto
    Valentin Fuster
    Zahi A. Fayad
    Willem J. M. Mulder
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 835 - 852
  • [5] Perspectives and opportunities for nanomedicine in the management of atherosclerosis
    Lobatto, Mark E.
    Fuster, Valentin
    Fayad, Zahi A.
    Mulder, Willem J. M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) : 835 - 852
  • [6] Application Perspectives of Nanomedicine in Cancer Treatment
    Hou, Shanshan
    Hasnat, Muhammad
    Chen, Ziwei
    Liu, Yinong
    Faran Ashraf Baig, Mirza Muhammad
    Liu, Fuhe
    Chen, Zelong
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Perspectives and challenges of nanomedicine in gene silencing
    [J]. 1600, Advanstar Communications Inc. (38):
  • [8] Pharmacological perspectives
    Fournier, M
    Guerin, JC
    [J]. REVUE DES MALADIES RESPIRATOIRES, 1998, 15 : S64 - S65
  • [9] Pharmacological perspectives
    不详
    [J]. International Journal of Obesity, 1999, 23 (Suppl 5) : S16 - S17
  • [10] Erratum: Perspectives and opportunities for nanomedicine in the management of atherosclerosis
    Mark E. Lobatto
    Valentin Fuster
    Zahi A. Fayad
    Willem J. M. Mulder
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 963 - 963
12345